Evidence map›Paper›PMID 41361693›Full record

ArticleEMBO reports2026

A low-level Cdkn1c/p57

Baptiste Mida, Nathalie Lehmann, Rosette Goïame, Fanny Coulpier, Kamal Bouhali, Isabelle Barbosa, Hervé le Hir, Morgane Thomas-Chollier, Evelyne Fischer, Xavier Morin

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Baptiste MidaInstitut de Biologie de l'Ecole Normale Supérieure (IBENS), CNRS, Inserm, Ecole Normale Supérieure, Sorbonne University, Collège Doctoral, Paris, 75005, France.ORCID 0009-0008-8969-7153
Nathalie LehmannInstitut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.
Rosette GoïameInstitut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.
Fanny CoulpierGenomiqueENS, Institut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.
Kamal BouhaliInstitut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.
Isabelle BarbosaInstitut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.
Hervé le HirInstitut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.ORCID 0000-0001-7964-9221
Morgane Thomas-ChollierInstitut de Biologie de l'ENS (IBENS), Département de biologie, Ecole Normale Supérieure, CNRS, INSERM, PSL Research University, Paris, 75005, France.
Evelyne Fischer *Institut de Biologie de l'Ecole Normale Supérieure (IBENS), CNRS, Inserm, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France. evelyne.fischer@ens.fr.ORCID 0000-0001-5054-1444
Xavier Morin *Institut de Biologie de l'Ecole Normale Supérieure (IBENS), CNRS, Inserm, Ecole Normale Supérieure, PSL Research University, Paris, 75005, France. xavier.morin@ens.fr.ORCID 0000-0001-9999-0355

Funding

Agence Nationale de la Recherche (ANR) ANR-10-INBS-09Agence Nationale de la Recherche (ANR) ANR-10-LABX-54 MEMO LIFEAgence Nationale de la Recherche (ANR) investissements d'avenirAgence Nationale de la Recherche (ANR) SYMASYM ANR-18-CE16-0021-01Fondation pour la Recherche Médicale (FRM) FRM EQU202003010547Ministère de l'Enseignement supérieur et de la Recherche (MESR) bourse doctorale
6 · The paper itself

Abstract

During vertebrate neurogenesis, a transition from symmetric proliferative to asymmetric neurogenic divisions is critical to balance growth and differentiation. Using single-cell RNA-seq data from the chick embryonic neural tube, we identify the cell cycle regulator Cdkn1c as a key regulator of this transition. While Cdkn1 is classically associated with neuronal cell cycle exit, we show that its expression initiates at low levels in neurogenic progenitors. Functionally targeting the onset of this expression impacts the course of neurogenesis: Cdkn1c knockdown impairs neuron production by favoring proliferative symmetric divisions. Conversely, inducing a low-level Cdkn1c misexpression in self-expanding progenitors forces them to prematurely undergo neurogenic divisions. Cdkn1c exerts this effect primarily by inhibiting the CyclinD1-CDK4/6 complex and G1 phase lengthening. We propose that Cdkn1c acts as a dual driver of the neurogenic transition whose low level of expression first controls the progressive entry of progenitors into neurogenic modes of division before higher expression mediates cell cycle exit in daughter cells. This highlights that the precise control of neurogenesis regulators' expression sequentially imparts distinct functions essential for proper neural development.

Indexed as

Cyclin-Dependent Kinase Inhibitor p57Neural Stem CellsNeurogenesisSpinal CordAnimalsCell CycleCell DifferentiationCell DivisionCell ProliferationChick EmbryoGene Expression Regulation, DevelopmentalNeural TubeNeuronsCyclin-Dependent Kinase Inhibitor p57Cdkn1cCell CycleModes of DivisionNeurogenesisSingle-cell Transcriptomics

Identifiers

PMID41361693
PMCPMC12852696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.